<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">
Skip to content
genoTYPER-NEXT Cover Thumbnail


Rapid, Scalable, and Ultra-Sensitive Validation of Allele-Specific Gene Editing Events with genoTYPER-NEXT™

About the Case Study

This case study focuses on a collaboration between Azenta and a large pharmaceutical client to develop a more effective approach for screening engineered cell lines via an automated, interactive NGS-based platform. This powerful technology permits the identification of all classes of genetic disruptions, including mono-allelic, homozygous, and heterozygous biallelic modifications.

Download Now

For technical support questions, please contact our Next Generation Sequencing team

(877) 436-3949 ext. 1 | ngs@azenta.com